ONK Therapeutics
ONK Therapeutics's Overview
ONK Therapeutics is an innovative clinical-stage immuno-oncology company headquartered in Galway, Ireland, with significant operations in San Diego, CA. The company is dedicated to developing and commercializing a portfolio of next-generation, off-the-shelf, dual-targeted natural killer (NK) cell therapies. Their approach focuses on engineering NK cells to express Chimeric Antigen Receptors (CARs) and other targeting moieties to enhance their anti-tumor activity, persistence, and ability to overcome the tumor microenvironment, aiming to provide new treatment options for patients with cancer.
Where is ONK Therapeutics's Headquarters?
HQ Function
Serves as the company's primary research and development (R&D) center, focusing on the discovery and preclinical development of novel NK cell therapies. It also houses core corporate functions and strategic leadership.
Notable Features:
Located within the National University of Ireland (NUI) Galway's Business Innovation Centre, facilitating access to advanced laboratory facilities, scientific talent, and a collaborative academic research environment.
Work Culture:
A mission-driven, innovative, and collaborative work culture. Teams are focused on scientific excellence and translating cutting-edge research into therapies for cancer patients, fostering a dynamic and intellectually stimulating environment.
HQ Significance:
Its Galway HQ leverages Ireland's strong biopharmaceutical sector, talent pool, and supportive ecosystem for life sciences innovation, crucial for its R&D-intensive operations.
Values Reflected in HQ: The headquarters' setting and function reflect values of innovation, scientific rigor, collaboration with academia, and a commitment to advancing medical science for patient benefit.
Location:
ONK Therapeutics operates with a global outlook, with its primary R&D and corporate headquarters in Galway, Ireland, and a significant operational hub in San Diego, USA. This dual presence allows the company to leverage talent and resources in both Europe and North America, supporting its global clinical development programs, regulatory interactions, and strategic partnerships for its NK cell therapy pipeline.
Street Address:
Unit 15, Block D, Business Innovation Centre, NUI Galway, University Road
City:
Galway
State/Province:
County Galway
Country:
Ireland
ONK Therapeutics's Global Presence
San Diego, California/USA
Address: 9920 Pacific Heights Blvd, Suite 150, San Diego, CA 92121
Facilitates engagement with the US FDA, clinical trial sites, potential partners, and investors in the significant US oncology market.
Buying Intent Signals for ONK Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of ONK Therapeutics
As of April 2025, ONK Therapeutics' leadership includes:
Investors of ONK Therapeutics
ONK Therapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
ONK Therapeutics has significantly strengthened its executive leadership team over the past 12 months with key appointments in manufacturing, finance, and business development, positioning the company for its next phase of growth and clinical advancement.
New Appointments:
Technology (Tech Stack) used by ONK Therapeutics
Discover the tools ONK Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ONK Therapeutics Email Formats and Examples
ONK Therapeutics likely utilizes common professional email formats. While not publicly confirmed, a prevalent structure often involves the first initial followed by the last name, or first name separated by a dot from the last name.
[first_initial][last]@onktherapeutics.com or [first].[last]@onktherapeutics.com
Format
jdoe@onktherapeutics.com or jane.doe@onktherapeutics.com
Example
75%
Success rate
News and media
onktherapeutics.com • February 13, 2024
ONK Therapeutics Appoints Hugh Prestwood as Chief Business Officer
ONK Therapeutics announced the appointment of Hugh Prestwood as its Chief Business Officer. Mr. Prestwood brings extensive experience in biopharmaceutical business development, corporate strategy, and commercial planning to ONK as it advances its pipeline of next-generation NK cell therapies....more
onktherapeutics.com • January 8, 2024
ONK Therapeutics Provides Year-End 2023 Corporate Update and Highlights Key Milestones for 2024
ONK Therapeutics provided a corporate update detailing significant progress in 2023, including advancing its lead NK cell therapy candidate ONKT102 towards clinical trials, expanding its research pipeline, and strengthening its leadership team. The company outlined key anticipated milestones for 2024, focusing on clinical trial initiation and further platform development....more
onktherapeutics.com • September 26, 2023
ONK Therapeutics Appoints Dr Delia O’Donovan as Chief Manufacturing Officer
ONK Therapeutics announced the appointment of Delia O’Donovan, PhD, as its Chief Manufacturing Officer (CMO). Dr O’Donovan will be responsible for all manufacturing operations, including process development, quality control, and supply chain management for ONK’s portfolio of NK cell therapies....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including ONK Therapeutics, are just a search away.